Skip to main content

Increased Incidence of Chronic Conditions Instrumental for Global Non-alcoholic Steatohepatitis (NASH) Biomarker Market Growth

According to Inkwood Research, the Global Non-alcoholic Steatohepatitis (NASH) Biomarker Market is predicted to record a CAGR of 20.65% in terms of revenue during the forecasting years of 2021-2028.

“Browse 49 Market Data Tables and 42 Figures spread over 167 Pages, along with an in-depth TOC on the Global Non-alcoholic Steatohepatitis (NASH) Biomarker Market Forecast 2021-2028.”

REQUEST CUSTOMIZATION LINK - https://www.inkwoodresearch.com/request-for-custom-report/

REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/non-alcoholic-steatohepatitis-biomarker-market/

VIEW TABLE OF CONTENT LINK - https://www.inkwoodresearch.com/reports/non-alcoholic-steatohepatitis-biomarker-market/#table-of-contents

BUY NOW- https://www.inkwoodresearch.com/reports/non-alcoholic-steatohepatitis-biomarker-market/

 

Non-alcoholic steatohepatitis (NASH) is characterized by a destructive form of non-alcoholic fatty liver disease (NAFLD). The condition often progresses to more severe disorders, including cirrhosis and hepatocellular carcinoma. As a result, NASH is likely to even surpass the hepatitis C virus infection, thereby becoming the leading cause of liver transplantation, worldwide, over the upcoming decade. 

Rising Prevalence of Chronic Diseases to Drive Market Growth

Non-alcoholic fatty liver disease (NAFLD) is a significant factor accredited to the rising incidence of liver disease, across the globe. NAFLD entails extra fat in individuals’ liver, who consume less or no alcohol. Besides, obesity and insulin resistance are among the condition’s major causes. 

On the other hand, the prevalence of alcoholic fatty liver and liver cancer cases is rapidly growing, as the number of alcoholics increase, annually. Likewise, the incidence of hepatocellular carcinoma is estimated to be 50 million, worldwide, while more than 15 million people in the United States are diagnosed with alcoholic fatty liver. Hence, the therapeutic choices available for liver cancer and alcoholic fatty liver, play an essential role in treating such diseases. 



To know more about this report, request a free sample copy.

Pharma & CRO Industry is the Leading End-User

The pharma and contract research organizations (CROs) division is anticipated to display a lucrative growth rate, over the upcoming years. The strong growth is accredited to the increased demand for non-invasive NASH diagnostic and monitoring tools in the ongoing clinical trials, particularly by CROs as well as pharmaceutical manufacturers. In addition, numerous enterprises are involved in therapeutics investigations for NASH. However, factors such as unknown etiology, complex pathophysiology, and expensive treatment for NASH, are expected to limit the segment’s revenue growth, over the forecast period. Besides, during the drug’s clinical trial, the routine monitoring of drug therapy is ideally non-invasive. This factor is projected to bolster the adoption of biomarker tests, predominantly in terms of NASH diagnostics.

North America Dominated the Global Market in 2020

The growing incidence of obesity and diabetes, the projected launch of pipeline molecules, as well as the early diagnosis of NASH are accredited to North America’s market growth. Moreover, favorable reimbursement policies within the region’s healthcare infrastructure, coupled with the easy availability of innovative therapeutics, play an essential role in augmenting the market growth.

The competitive rivalry within the global market is expected to be moderate, on account of the unavailability of treatment. Key market players concentrate on partnerships and research and development, for introducing new products into the market. 

Leading enterprises operating in the market include, Novartis AG, Pfizer Inc, Merck & Co, AstraZeneca, etc.

About Inkwood Research

Inkwood Research specializes in syndicated & customized research reports and consulting services. Market intelligence studies with relevant fact-based research are customized across industry verticals such as technology, automotive, chemicals, materials, healthcare, and energy, with an objective comprehension that acknowledges the business environments. Our geographical analysis comprises North & South America, CEE, CIS, Middle East, Europe, Asia, and Africa.

Contact Us

https://www.inkwoodresearch.com

sales@inkwoodresearch.com

+1 857-302-4704

Related Reports:

GLOBAL BARIATRIC SURGERY MARKET

GLOBAL HERNIA REPAIR DEVICES AND CONSUMABLES MARKET

GLOBAL KIDNEY CANCER THERAPEUTICS AND DIAGNOSTICS MARKET

GLOBAL EXTRA CORPOREAL MEMBRANE OXYGENATION (ECMO) SYSTEM MARKET

 

 

Labels:

Comments

Post a Comment

Popular posts from this blog

Surging Chronic Conditions to Supplement Global Magnetic Resonance Imaging (MRI) Systems Market Growth

Inkwood Research anticipates that the Global Magnetic Resonance Imaging (MRI) Systems Market is evaluated to record a CAGR of 5.50% in terms of revenue during the forecasted years of 2021-2028. “Browse 53 Market Data Tables and 48 Figures spread over 229 Pages, along with an in-depth TOC on the Global Magnetic Resonance Imaging (MRI) Systems Market Forecast 2021-2028.”   BUY NOW - https://www.inkwoodresearch.com/reports/mri-systems-market/   Magnetic resonance imaging (MRI) is characterized as a non-invasive imaging technology aiming to produce detailed 3-D (three-dimensional) anatomical images. It is typically used for the detection and diagnosis of diseases, in addition to monitoring further treatment. MRI systems are based on a sophisticated technology that detects changes in the rotational axis direction of protons found in water that constitutes living tissues. Increasing Prevalence of Chronic Conditions to Augment Market Growth The four most critical types of chron
Post a Comment
Read more

Global Pharmacy Automation Equipment Market to Register Notable Growth Given the Decentralization of Pharmacies

Inkwood Research anticipates that the Global Pharmacy Automation Equipment Market is evaluated to project a CAGR of 7.93% in terms of revenue during the forecasting years of 2021-2028. “Browse 39 Market Data Tables and 39 Figures spread over 200 Pages, along with an in-depth TOC on the Global Pharmacy Automation Equipment Market Forecast 2021-2028.”   To know more about this report, request a free sample copy. Pharmacy automation is characterized as decentralized or centralized automated dispensing, labeling, packing, and other systems, that help minimize dispensing errors. Moreover, it also plays a vital role in terms of improving the workflow efficiency of hospital nursing staff as well as pharmacies. Decentralization of Pharmacies to Augment Market Growth Decentralized pharmacy services are considered in order to refer to a practice model where a pharmacist located on the ward is primarily responsible for distribution and clinical services, including possibly order entry
Post a Comment
Read more

Development of Target Based Drug Drives the Global Protein Sequencing Market at 6.47%

According to a new market research report published by Inkwood Research, Global Protein Sequencing Market is estimated to project a CAGR of 6.47% during the forecasting years of 2020-2028. "Browse 39 Market Data Tables and 44 Figures spread over 147 Pages, along with an in-depth TOC on the Global Protein Sequencing Market Forecast 2020-2028.” REQUEST FREE SAMPLE LINK - https://www.inkwoodresearch.com/reports/protein-sequencing-market/#request-free-sample Protein sequencing provides information regarding the amino acids that constitute a protein. While the sequencing process is performed, amino acids are consecutively removed from the n-terminal end of the protein strand and identified in the order they occur in the protein. Growing Focus on Target-Based Drug Development Since the last few years, a growing number of findings based on proteomics have boosted innovative drug development. Moreover, many drugs have been developed with an emphasis on single protein target
Post a Comment
Read more